|
Morgan, Melinda L; Cook, Ian A; Rapkin, Andrea J et al. (2007) Neurophysiologic changes during estrogen augmentation in perimenopausal depression. Maturitas 56:54-60
|
|
Hunter, Aimee M; Leuchter, Andrew F; Morgan, Melinda L et al. (2006) Changes in brain function (quantitative EEG cordance) during placebo lead-in and treatment outcomes in clinical trials for major depression. Am J Psychiatry 163:1426-32
|
|
Morgan, Melinda L; Witte, Elise A; Cook, Ian A et al. (2005) Influence of age, gender, health status, and depression on quantitative EEG. Neuropsychobiology 52:71-6
|
|
Cook, Ian A; Leuchter, Andrew F; Morgan, Melinda L et al. (2005) Changes in prefrontal activity characterize clinical response in SSRI nonresponders: a pilot study. J Psychiatr Res 39:461-6
|
|
Morgan, Melinda L; Cook, Ian A; Rapkin, Andrea J et al. (2005) Estrogen augmentation of antidepressants in perimenopausal depression: a pilot study. J Clin Psychiatry 66:774-80
|
|
Marie-Mitchell, Ariane; Leuchter, Andrew F; Chou, Chih-Ping et al. (2004) Predictors of improved mood over time in clinical trials for major depression. Psychiatry Res 127:73-84
|
|
Stubbeman, William F; Leuchter, Andrew F; Cook, Ian A et al. (2004) Pretreatment neurophysiologic function and ECT response in depression. J ECT 20:142-4
|
|
Cook, Ian A; Leuchter, Andrew F; Morgan, Melinda L et al. (2004) Longitudinal progression of subclinical structural brain disease in normal aging. Am J Geriatr Psychiatry 12:190-200
|
|
Krell, Heather V; Leuchter, Andrew F; Morgan, Melinda et al. (2004) Subject expectations of treatment effectiveness and outcome of treatment with an experimental antidepressant. J Clin Psychiatry 65:1174-9
|
|
Leuchter, Andrew F; Morgan, Melinda; Cook, Ian A et al. (2004) Pretreatment neurophysiological and clinical characteristics of placebo responders in treatment trials for major depression. Psychopharmacology (Berl) 177:15-22
|
Showing the most recent 10 out of 44 publications
